Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ChemoCentryx, Inc.CCXI · Entity 122928 | Director | May 20, 2022 | May 24, 2022 |
| MOODYS CORP /DE/MCO · Entity 386 | Director | March 18, 2021 | March 19, 2021 |
| ViewRay, Inc.VRAY · Entity 111118 | Director | January 02, 2019 | January 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ChemoCentryx, Inc.
Report date May 20, 2022 · Filed May 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,749 |
Reported balance
After 2022-05-20 transaction · row 1
1 source rowRow 1 · 2022-05-20 · Exercise / conversion · Acquired 7,726 · Balance 72,749 F1: Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-20 · Exercise / conversion · Disposed 7,726 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. F3: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.
F2: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F3: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.
MOODYS CORP /DE/
Report date March 18, 2021 · Filed March 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 89,487.963 |
Ending reported balance
After 2021-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-03-18 · Grant · Acquired 109 · Balance 89,471.388 F1: Restricted Stock deferred dividend reinvestment accrual. Row 2 · 2021-03-18 · Grant · Acquired 16.575 · Balance 89,487.963 F2: RSU deferred dividend reinvestment accrual. |
| Phantom Stock Units (Deferred Performance Shares)SEC Table II · derivative / convertible security | Direct | 1,885.499 |
Reported balance
After 2021-03-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-03-18 · Grant · Acquired 4.056 · Balance 1,885.499 F3: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F4: The security converts to common stock on a one-for-one basis. F5: These units are to be settled in stock after the Reporting Person's retirement. |
| Dividend EquivalentSEC Table II · derivative / convertible security | Direct | 1.393 |
Reported balance
After 2021-03-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-18 · Grant · Acquired 1.393 · Balance 1.393 F6: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock deferred dividend reinvestment accrual.
F2: RSU deferred dividend reinvestment accrual.
F3: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares.
F4: The security converts to common stock on a one-for-one basis.
F5: These units are to be settled in stock after the Reporting Person's retirement.
F6: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award.
ViewRay, Inc.
Report date January 02, 2019 · Filed January 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 689,046 |
Ending reported balance
After 2019-01-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-01-02 · Grant · Acquired 8,928 · Balance 670,378 F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000. Row 2 · 2019-01-02 · Grant · Acquired 18,668 · Balance 689,046 F3: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date.
F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000.
F3: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Federal Street Acquisition Corp.
Report date January 04, 2019 · Filed January 04, 2019
Section 16 reporting ended · disclosed 2019-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-01-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-01-04 · Conversion · Acquired 25,000 · Balance 25,000 F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date. Row 2 · 2019-01-04 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: In accordance with the Amended and Restated Agreement and Plan of Merger, dated as of December 19, 2018 by and among the Issuer, Agiliti, Inc., Agiliti Holdco, Inc. and the other parties thereto, at the closing of the business combination contemplated thereby, Mr. McKinnell disposed of 25,000 shares of the Issuer's Class A Common Stock in exchange for 25,000 shares of common stock of Agiliti, Inc. |
| Class F Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-01-04 · Conversion · Disposed 25,000 · Balance 0 F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date.
F2: In accordance with the Amended and Restated Agreement and Plan of Merger, dated as of December 19, 2018 by and among the Issuer, Agiliti, Inc., Agiliti Holdco, Inc. and the other parties thereto, at the closing of the business combination contemplated thereby, Mr. McKinnell disposed of 25,000 shares of the Issuer's Class A Common Stock in exchange for 25,000 shares of common stock of Agiliti, Inc.
PFIZER INC
Report date February 28, 2007 · Filed March 02, 2007
Section 16 reporting ended · disclosed 2007-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,134,851 |
Reported balance
After 2007-02-28 transaction · row 1
1 source rowRow 1 · 2007-02-28 · Tax withholding · Disposed 35,309 · Balance 2,134,851 |
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 100,460 |
Reported balance
After 2007-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2007-02-28 · Grant · Acquired 240 · Balance 100,460 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 40,894 |
Reported balance
Holding disclosure · report date 2007-02-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 40,894 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 212,688 |
Reported balance
Holding disclosure · report date 2007-02-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 212,688 |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2003 Filed Jun 2, 2003 18:07 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 154 | $31.02 Strike: $0.00 | $4,777.08 |
DisclosureSEC source: 0000078003-03-000070 · mck349.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,493 Underlying: Common Stock · 154 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:03 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 373 | $33.53 Strike: $0.00 | $12,506.69 |
DisclosureSEC source: 0000078003-03-000061 · mck335.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,339 Underlying: Common Stock · 373 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.